Filing Flows › Comparisons › HTFL vs MDXG
Heartflow vs Mimedx Group: HTFL and MDXG compared
Heartflow is the larger company: $64.1M of revenue in its latest quarter (Q2 2026) against $62.3M for Mimedx Group (Q3 2026). Heartflow is growing faster (+48% against -45% a year earlier). Mimedx Group is more profitable, with an operating margin of -18.8% against -27.9%.
Where the money goes: HTFL and MDXG
Heartflow (HTFL) · Q2 2026
Heartflow, Q2 2026: revenue $64.1M (+48% year over year), operating margin -27.9%, net loss $15.7M, operating cash flow −$8.6M. The chart follows the revenue to costs, profit and cash.
Mimedx Group (MDXG) · Q3 2026
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
| Heartflow (HTFL) | Mimedx Group (MDXG) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $64.1M | $62.3M |
| Revenue growth, Y/Y | +48% | -45% |
| Operating margin | -27.9% | -18.8% |
| Net earnings | −$15.7M | −$8.7M |
| Net margin | -24.6% | -13.9% |
| Operating cash flow | −$8.6M | $3.9M |
| Free cash flow | — | $3.8M |
| Market value | — | $683M |
| Analysts’ mean target | — | $7.00 |
Where the revenue comes from
Mimedx Group
- Surgical: $40.0M (64%)
- Wound: $22.3M (36%)
Questions
Which is bigger, Heartflow or Mimedx Group?
Heartflow is the larger company: $64.1M of revenue in its latest quarter (Q2 2026) against $62.3M for Mimedx Group (Q3 2026).
Is Heartflow or Mimedx Group growing faster?
Heartflow is growing faster (+48% against -45% a year earlier).
Which is more profitable, Heartflow or Mimedx Group?
Mimedx Group is more profitable, with an operating margin of -18.8% against -27.9%.
More: Heartflow earnings · how Heartflow makes money · Mimedx Group earnings · how Mimedx Group makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Oct 28, 2026). Fiscal quarters can end on different dates. Not investment advice.